Leila Mohammadnezhad

Dr. Leila Mohammadnezhad

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology Unit - “P. Giaccone” University Hospital, University of Palermo, Piazza delle Cliniche 2, 90100, Palermo, Italy.
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
Leila MohammadnezhadLeila Mohammadnezhad
Leila Mohammadnezhad
Mojtaba Shekarkar azgomiMojtaba Shekarkar azgomi
Mojtaba Shekarkar azgomi
MMMarco Pio La Manna
Marco Pio La Manna
GSGuido Sireci
Guido Sireci
CRChiara Rizzo
Chiara Rizzo
NCNadia Caccamo
Nadia Caccamo
Immune cells undergo different metabolic pathways or immunometabolisms to interact with various antigens. Immunometabolism links immunological and metabolic processes and is critical for innate and adaptive immunity. Although metabolic reprogramming is necessary for cell differentiation and proliferation, it may mediate the imbalance of immune homeostasis, leading to the pathogenesis and development of some diseases, such as autoimmune diseases. Here, we discuss the effects of metabolic changes in autoimmune diseases, exerted by the leading actors of innate immunity, and their role in autoimmunity pathogenesis, suggesting many immunotherapeutic approaches.

28 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
Bartolo TamburiniBartolo Tamburini
Bartolo Tamburini
MMMarco Pio La Manna
Marco Pio La Manna
LBLidia La Barbera
Lidia La Barbera
Leila MohammadnezhadLeila Mohammadnezhad
Leila Mohammadnezhad
GBGiusto Davide Badami
Giusto Davide Badami
NCNadia Caccamo
Nadia Caccamo
Inflammatory bowel disease (IBD) is an increasingly urgent medical problem that strongly impairs quality of life for patients. A global rise in incidence has been observed over the last few decades, with the highest incidence rates recorded in North America and Europe. Still, an increased incidence has been reported in the last ten years in newly industrialized countries in Asia, including China and India, both with more than one billion inhabitants. These data underline that IBD is an urgent global health problem. In addition, it is estimated that between 20% and 30% of IBD patients will develop colorectal cancer (CRC) within their lifetime and CRC mortality is approximately 50% amongst IBD patients. Although the exact etiology of IBD is still being defined, it is thought to be due to a complex interaction between many factors, including defects in the innate and adaptive immune system; microbial dysbiosis, i.e., abnormal levels of, or abnormal response to, the gastrointestinal microbiome; a genetic predisposition; and several environmental factors. At present, however, it is not fully understood which of these factors are the initiators of inflammation and which are compounders. The purpose of this review is to analyze the complex balance that exists between these elements to maintain intestinal homeostasis and prevent IBD or limit adverse effects on people’s health.

1 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MMMarco Pio La Manna
Marco Pio La Manna
Diana Di LibertoDiana Di Liberto
Diana Di Liberto
MPMarianna Lo Pizzo
Marianna Lo Pizzo
Leila MohammadnezhadLeila Mohammadnezhad
Leila Mohammadnezhad
Mojtaba Shekarkar azgomiMojtaba Shekarkar azgomi
Mojtaba Shekarkar azgomi
NCNadia Caccamo
Nadia Caccamo
Glial tumors alone account for 40% of all CNS tumors and present a low survival rate. The tumor microenvironment is a critical regulator of tumor progression and therapeutic effectiveness in glioma. Growing evidence from numerous studies of human solid tumor-infiltrating CD8+ T cells indicates that tissue-resident memory T cells (TRM) represent a substantial subpopulation of tumor-infiltrating lymphocytes (TILs). Although it is reported that some types of cancer patients with high immune infiltration tend to have better outcomes than patients with low immune infiltration, it seems this does not happen in gliomas. This study aimed to characterize TRMs cells in the glioma tumor microenvironment to identify their potential predictive and prognostic role and the possible therapeutic applications. Fluorescence activated cell sorting (FACS) analysis and immunofluorescence staining highlighted a statistically significant increase in CD8+ TRM cells (CD103+ and CD69+ CD8+ T cells) in gliomas compared to control samples (meningioma). In-silico analysis of a dataset of n = 153 stage IV glioma patients confirmed our data. Moreover, the gene expression analysis showed an increase in the expression of TRM-related genes in tumor tissues compared to normal tissues. This analysis also highlighted the positive correlation between genes associated with CD8+ TRM and TILs, indicating that CD8+ TRMs cells are present among the infiltrating T cells. Finally, high expression of Integrin subunit alpha E (ITGAE), the gene coding for the integrin CD103, and high CD8+ TILs abundance were associated with more prolonged survival, whereas high ITGAE expression but low CD8+ TILs abundance were associated with lower survival.

Verified
Journal Article
Open access
PDF file
Leila MohammadnezhadLeila Mohammadnezhad
Leila Mohammadnezhad
Mojtaba Shekarkar azgomiMojtaba Shekarkar azgomi
Mojtaba Shekarkar azgomi
MMMarco Pio La Manna
Marco Pio La Manna
Giuliana GugginoGiuliana Guggino
Giuliana Guggino
CBCirino Botta
Cirino Botta
NCNadia Caccamo
Nadia Caccamo
Primary Sjogren syndrome (pSS) is the second most common autoimmune disorder worldwide, which, in the worst scenario, progresses to Non-Hodgkin Lymphoma (NHL). Despite extensive studies, there is still a lack of knowledge about developing pSS for NHL. This study focused on cells’ signaling in pSS progression to the NHL type of diffuse large B-cell lymphoma (DLBCL). Using bulk RNA and single cell analysis, we found five novel pathologic-independent clusters in DLBCL based on cells’ signaling. B-cell receptor (BCR) signaling was identified as the only enriched signal in DLBCL and pSS peripheral naive B-cells or salivary gland-infiltrated cells. The evaluation of the genes in association with BCR has revealed that targeting CD79A, CD79B, and LAMTOR4 as the shared genes can provide novel biomarkers for pSS progression into lymphoma.

20 October 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Sara JerónimoSara Jerónimo
Sara Jerónimo
AGAlmudena González Garcia
Almudena González Garcia
Jose De La FuenteJose De La Fuente
Jose De La Fuente
Valeria BlandaValeria Blanda
Valeria Blanda
Mojtaba Shekarkar azgomiMojtaba Shekarkar azgomi
Mojtaba Shekarkar azgomi
GSGuido Sireci
Guido Sireci
Anaplasma phagocytophilum are obligatory intracellular bacteria that preferentially replicate inside leukocytes by utilizing biological compounds and processes of these primary host defensive cells. In this study, bioinformatics analysis was conducted to further characterize A. phagocytophilum–host interactions using the neutrophil-like model of human Caucasian promyelocytic leukemia HL60 cells. We detected a hierarchy of molecules involved in A. phagocytophilum-HL60 interactions with overrepresentation in infected human cells of proteins involved in the reactive oxygen species (ROS) pathway and cell surface monocyte markers. As A. phagocytophilum phagocytosis by neutrophils is inhibited, the results suggested a possible explanation for our bioinformatics data: radical oxygen compounds could induce the killing of bacteria activating NETosis, a unique form of defense mechanism resulting in cell death that is characterized by the release of decondensed chromatin and granular contents to the extracellular space, forming neutrophil extracellular traps (NETs) to eliminate invading microorganisms. Thus, we confirmed the existence of a low NETosis induced in A. phagocytophilum-infected cells by immunofluorescence (IF) experiments. These results provide new insights into the complex mechanisms that govern immune response during A. phagocytophilum host interactions.